DiscGenics® Automates their Quality Processes
DiscGenics® Automates their Quality Processes
3 Pages© Copyright 2019 www.etq.com Case Study / DiscGenics DiscGenics® Automates their Quality Processes DiscGenics is a biotechnology company that is developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc. Currently, Disc- Genics is developing Injectable Discosphere Cell Therapy (IDCT), which is an off-the-shelf injectable therapeutic based on regenerative medicine and progenitor cell sci- ence to treat pain associated with degenerative disc disease. DiscGenics is the only company to utilize allogeneic therapeutic progenitor cells derived from intervertebral disc. DiscGenics have a patented technology for isolating cells directly from adult human disc tissue and expanding these cells into their proprietary Discogenic Cells. Di
